Related Experiment Video
Updated: Jul 15, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Sexual dysfunction after treatment for testicular cancer: a systematic review
1Department of Primary Care and Population Sciences, Royal Free and University College London Medical School, University College London, Rowland Hill Street, London NW3 2PF, UK. i.nazareth@pcps.ucl.ac.uk
Objectives:
We aimed to assess the nature and risk of sexual dysfunction in men after treatment for testicular cancer.
Method:
Systematic review of sexual dysfunction in men treated for testicular cancer. The odds ratio or proportions of subjects with reduced sexual drive, erectile dysfunction or orgasmic/ejaculatory dysfunction was calculated.
Results:
A detailed review of 79 of the 227 citations was conducted. The highest level of evidence found, were controlled studies. Six controlled studies examined sexual function in 709 patients after they had received treatment. Seven uncontrolled studies examined sexual function in 337 subjects before and after treatment for testicular cancer. Most studies were limited by low response rates, use of unvalidated questionnaires and inclusion of a variety of treatment modalities. Few assessed psychological function and none examined its possible interaction with sexual dysfunction. Meta-analysis of the controlled studies indicated significantly reduced or absent orgasm (OR=4.62, 95% CI=2.47-8.63) together with erectile (OR=2.47, 95% CI=1.54-3.96) and ejaculatory dysfunction (OR=28.57, 95% CI=1.75-464.78) up to 2 years after treatment. Effects on sexual function were less consistent in the uncontrolled studies.
Conclusions:
The controlled studies indicate that sexual dysfunction persists for up to 2 years after treatment. However, better evidence is needed in studies that control for the impact of the testicular cancer, the treatment modality and psychological reactions to both.
Insights
Men treated for testicular cancer experience persistent sexual dysfunction, including reduced orgasm, erectile issues, and ejaculatory problems, for up to two years post-treatment. Further research is needed to clarify these effects.
Area of Science:
- Oncology
- Urology
- Sexual Medicine
Background:
- Testicular cancer treatment can significantly impact male reproductive health.
- Sexual dysfunction is a common concern for survivors, affecting quality of life.
Purpose of the Study:
- To systematically review and assess the nature and risk of sexual dysfunction in men following testicular cancer treatment.
- To quantify the prevalence of specific sexual dysfunctions, including reduced libido, erectile dysfunction, and orgasmic/ejaculatory dysfunction.
Main Methods:
- Systematic review of published literature on sexual dysfunction in testicular cancer patients.
- Meta-analysis of controlled studies and analysis of uncontrolled studies to calculate odds ratios and proportions of sexual dysfunction.
- Inclusion of data from 709 patients in controlled studies and 337 in uncontrolled studies.
Main Results:
- Meta-analysis of controlled studies revealed significantly increased odds of reduced/absent orgasm (OR=4.62), erectile dysfunction (OR=2.47), and ejaculatory dysfunction (OR=28.57) up to 2 years post-treatment.
- Uncontrolled studies showed less consistent effects on sexual function.
- Limitations include low response rates, unvalidated questionnaires, and varied treatment modalities across studies.
Conclusions:
- Sexual dysfunction, particularly concerning orgasm, erectile function, and ejaculation, persists for up to two years after testicular cancer treatment.
- High-quality evidence is required to control for confounding factors like the cancer itself, treatment type, and psychological impact.
Related Concept Videos
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Infertility in Males
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

